[1]
“Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives”, Swiss Med Wkly, vol. 150, no. 1718, p. w20264, Apr. 2020, doi: 10.4414/smw.2020.20264.